Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Vistide launched in Germany

Oct. 7, 1997

Abbott prepares and evaluates tetracyclic ketolides as antibacterials

Oct. 6, 1997

New antifungal antibiotic with sphingosine-like lipid moiety

Oct. 6, 1997

Korean research institute synthesizes potent DNA gyrase inhibitors

Oct. 6, 1997

Profile of a monobactam beta-lactamase inhibitor

Oct. 6, 1997

GS-4104 (Ro-64-0796): safety and pharmacokinetics in humans

Oct. 6, 1997

Taisho reports new macrolides termed "acylides"

Oct. 6, 1997

Korean researchers present novel 3-isoxazolylvinylcephalosporins

Oct. 3, 1997

R.W. Johnson identifies TCS inhibitor with potent antibacterial activity

Oct. 3, 1997

Microcide identifies cephalosporin with excellent Gram-positive activity

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...